Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 192

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 10
Chunk 192
---
  
     -  
     2,763 (4) 
    $156,838 
  
    former Chairman and CEO 
    2023 
     -  
     -  
     -  
     -  
     -  
     - 
  
    Nathen Fuentes,  
    2024 
    $224,913  
     -  
     -  
     -  
     1,971 (4) 
    $226,883 
  
    former CFO, Treasurer, and Secretary 
    2023 
    $18,192  
     -  
     -  
     -  
     -  
    $18,192 

(1)
Mr. Aminov was appointed Chaiman and Chief Executive Officer on August 8, 2024.

(2)
Ms. Yanez was appointed Chief Financial Officer, Treasurer, and Secretary on June 18, 2024.

(3)
The reported amounts represent the aggregate grant date fair value of the awards computed in accordance with Financial Accounting Standards
Board Account Standards Codification Topic 718, Stock Compensation, as modified or supplemented, or FASB ASC Topic 718. The
assumptions used in calculating the grant date fair value of the stock options reported in this column are set forth in Note 6 to our
Financial Statements for the year ended December 31, 2024 included in this Report

(4)
Amounts represent health insurance premiums paid.

(5) Amounts represent health insurance premiums paid,
car payments, car insurance payments, and club memberships costs.

Executive
Compensation Arrangements

Below
is a more detailed summary of the elements of our current executive compensation program as it relates to our named executive officers.

61

Employment
Agreements 

Erez
Aminov

 Effective
August 12, 2024, we entered into an employment agreement with Mr. Aminov, pursuant to which Mr. Aminov will serve as our Chief Executive
Officer and Chairman of our Board. Under his employment agreement, Mr. Aminov has agreed to devote reasonable business time and effort
to the business and affairs of the Company. Mr. Aminov’s employment agreement provides that his employment will be on an at-will
basis and can be terminated by either Mr. Aminov or our